Introduction: The RhinAsthma Patient Perspective (RAPP) was developed in Italian to assess the Health Related Quality of Life (HRQoL) impairment in patients with asthma and allergic rhinitis (AR) in daily practice.
Aim: To cross-culturally validate the Polish version.
Material And Methods: The Polish version was administered to patients suffering from asthma and rhinitis in a prospective observational study. Polish RAPP, along with SF-12, ACT, and a Symptomatologic VAS was filled in twice, with a 4-week interval between visits. At visit 2, a Global Rating Scale (GRS) was completed to assess any change in health status. Internal consistency, validity, reliability, discriminant ability and responsiveness to change as well as Minimal Important Difference were determined.
Results: The factor and confirmatory analysis revealed a unidimensional structure of RAPP. Internal consistency was satisfactory with Cronbach's α (visit 1 = 0.85, visit 2 = 0.89). High reliability (ICC = 0.89 and a CCC = 0.94) was found. Validity analyses showed good correlations of the Polish RAPP with Physical and Mental Component Scores of SF-12. In addition, RAPP adequately discriminated patients on the basis of the asthma control level and rhinitis severity ( < 0.03 for all the analyses), and demonstrated to be sensitive to change. MID value was 1 point.
Conclusions: The study confirmed the reliability and validity of the Polish version of RAPP demonstrating that it is a useful tool in the assessment of HRQoL in patients with asthma and comorbid allergic rhinitis, in clinical practice.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247060 | PMC |
| http://dx.doi.org/10.5114/ada.2020.93387 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical and psychological aspects in a group of allergic asthma patients and the impact on their health status perception.
Health Psychol Rep
September 2023
University of Parma, Parma, Italy.
Background: The interplay between physical and psychological symptoms frequently affects the health-related quality of life of asthma patients.
Participants And Procedure: This research aimed at assessing the psychological status of 60 patients attending their first/second doctor visit at which they were diagnosed with allergic asthma. Information on psychological distress was collected through the Symptom Questionnaire (SQ), personality traits were described through Cattell's 16-Personality Factor Questionnaire (16-PF), stress-related behavior was detected through the P Stress Questionnaire (PSQ), and the perceived quality of life was described with the Rhinasthma questionnaire.
Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach - ARIA-EAACI Task Force Report.
Allergy
July 2023
Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Biomarkers for the diagnosis, treatment and follow-up of patients with rhinitis and/or asthma are urgently needed. Although some biologic biomarkers exist in specialist care for asthma, they cannot be largely used in primary care. There are no validated biomarkers in rhinitis or allergen immunotherapy (AIT) that can be used in clinical practice.
View Article and Find Full Text PDFSymptom control and health-related quality of life in allergic rhinitis with and without comorbid asthma: A multicentre European study.
Clin Transl Allergy
February 2023
Institut Desbrest of Epidemiology and Santé Publique INSERM & Montpellier University, Montpellier, France.
Background: Allergic rhinitis (AR) is a major non-communicable disease that affects the health-related quality of life (HRQoL) of patients. However, data on HRQoL and symptom control in AR patients with comorbid asthma (AR + asthma) are lacking.
Methods: In this multicentre, cross-sectional study, patients with AR were screened and administered questionnaires of demographic characteristics and health conditions (symptoms/diagnosis of AR and asthma, disease severity level, and allergic conditions).
Rhinitis and Asthma Patient Perspective (RAPP): Clinical Utility and Predictive Value.
J Allergy Clin Immunol Pract
March 2022
Respiratory Unit for Continuity of Care, Istituti di Ricovero e Cura a Carattere Scientifico, Ospedale Policlinico San Martino, Genova, Italy.
Background: RhinAsthma Patient Perspective (RAPP) is the only validated tool for assessing of health-related quality of life (HRQoL) related to asthma and rhinitis in individual patients.
Objective: To compare the HRQoL burden among countries and explore the usefulness of RAPP as a complementary measure in disease management.
Methods: In this post hoc analysis of the RAPP International Study, the enrolled population was clustered into patients with controlled rhinitis and controlled asthma (CA/CR), uncontrolled rhinitis and controlled asthma (CA/UR), controlled rhinitis and uncontrolled asthma (UA/CR), and uncontrolled rhinitis and uncontrolled asthma (UA/UR).
Cross-cultural adaptation and validation of the RhinAsthma Patient Perspective (RAPP) in the Polish population.
Postepy Dermatol Alergol
February 2020
IRCCS Ospedale Policlinico San Martino, Università di Genova, Dipartimento di Medicina Interna (DiMI), Genova, Italy.
Introduction: The RhinAsthma Patient Perspective (RAPP) was developed in Italian to assess the Health Related Quality of Life (HRQoL) impairment in patients with asthma and allergic rhinitis (AR) in daily practice.
Aim: To cross-culturally validate the Polish version.
Material And Methods: The Polish version was administered to patients suffering from asthma and rhinitis in a prospective observational study.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!